Centre for Chronic Disease Control is a WHO collaborating centre for surveillance, capacity building and translational research in cardio-metabolic diseases.
WHO CC activities:
• To assist WHO in developing cardio-metabolic disease surveillance for countries in SEA region
• To support WHO in capacity building for the prevention and control of cardio-metabolic diseases among different stakeholders
• To work with WHO to develop collaboration, share experience and resources with other organizations regionally and globally for the protection and promotion of cardio-metabolic health
• To provide Support to WHO in the implementation of the Global HEARTS initiative
• To provide Support to WHO by developing Digital health innovations and evaluating them to expand chronic disease care delivery in primary health care settings
• In support of WHO, provide technical input that may inform the development of guidance on the use of total CVD risk assessment at the primary care level
• To provide technical support, as appropriate, to WHO in assessing digital health interventions for NCDs
Centre for Chronic Disease Control has been designated as an ICMR collaborating centre for excellence in recognition of the commendable achievements in biomedical research.
Cognitum ARO Consortium was officially launched on Sunday 27th August 2023 during the European Society of Cardiology Congress, Amsterdam.
This consortium, comprised of six world-class Academic Research Organizations (AROs), brings together global leaders in scientific and clinical excellence. The vision behind this initiative is to leverage the power of scientific and clinical excellence to create improved healthcare outcomes for our global community. The Cognitum Consortium unites a prestigious group of AROs from across the globe, who are known for their commitment to excellence and positive global impact. The founding member institutes include the Centre for Chronic Disease Control in India, Einstein ARO in Brazil, Imperial Clinical Trials Unit (ICTU) – Global in the UK, RemediumOne in Sri Lanka, The George Institute in Australia and the Mayosi Research Group, University of Cape Town in South Africa.
The digital health innovator technical support program is a multi-disciplinary program by the Centre for Cellular Molecular Platforms (C-CAMP) and the Centre for Chronic Disease Control (CCDC). It is intended to unleash the potential of digital health innovations through evidence-based insights for India and beyond. The program will help strengthen the fundamentals of digital health innovations and will pave the way for health innovators to receive the critical support they need to successfully bring their innovations to market and make a positive impact on public health.
CCDC is partnering with India Health Fund to establish a multidisciplinary Programme, the Digital Health Innovator Technical Support Programme (DHITSP), which will support start-ups and innovators in digital health. Together, we will offer comprehensive assistance, including scientific design evaluation, economic feasibility analysis, business planning, ecosystem fit assessment, and public health readiness evaluation. We will conduct detailed analyses of digital health interventions to ensure their scientific and technical soundness, broad applicability within health systems, and positive social impact.
As part of this partnership, CCDC will support innovators in generating valuable findings and scientific publications by providing evaluation, statistical analysis, and proposal writing assistance.
CCDC envisions to reduce chronic disease burden and promote innovative science that has the potential to improve human health through implementation and translational research.
Institutional Ethics Committee
Department of Health Research (DHR) Registration Number: EC/NEW/INST/2024/4768
Office of Human Research Protections (OHRP) FWA No: FWA00012746
Centre for Chronic Disease Control © 2026 All rights reserved.
